Verkkocontinuous subcutaneous insulin infusion (csii) therapy, or insulin pump therapy, is being used with increasing frequency for treating patients with.
Verkkoas an area of therapy with the best market potential and one of the most expensive global diseases, diabetes attracts the best healthcare players, who use innovative.